Colby Wolfe
Colby Wolfe, MBA, brings over 16 years of strategic supply chain and manufacturing expertise across biotech startups and global pharmaceutical enterprises. He has a proven track record building and scaling end-to-end biopharmaceutical supply operations from clinical development through commercial launch, with deep expertise in CMO network development, manufacturing strategy, and organizational scaling.
Most recently at Sanofi, Mr. Wolfe led supply chain transformation initiatives for rare disease products, identifying and correcting critical upstream safety stock models while achieving zero patient-impacting stockouts. Previously, as Executive Director of Supply Chain at Dyne Therapeutics, he built clinical supply chain infrastructure and established commercial supply networks managing $150M+ in annual budget. He also led US supply chain operations at Moderna during the COVID-19 pandemic response, scaling from zero to 600+ million doses produced and delivered. Earlier in his career, Mr. Wolfe held progressive leadership roles at Novartis, Bristol-Myers Squibb, and Teva Pharmaceuticals, managing complex supply networks and driving operational excellence across multiple modalities.
Mr. Wolfe holds an MBA in supply chain management and international business from Northeastern University and a BS in plant science from Temple University. He is a Certified Supply Chain Professional (CSCP) and a graduate of the Novartis Quest Leadership Journey program.